Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

The sabotage of cellular messaging, triggered by the formation of chronic stress granules in the brain, may be a key factor ...

Study suggests belly fat is a midlife indicator of Alzheimer’s disease Learn about the research on belly fat’s impact on ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

The project specifically focused on the hippocampus, a region of the brain that's not only crucial for memory but also ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

By Dr. Liji Thomas, MD New serine biomarkers offer hope for early Alzheimer’s detection and intervention. Study: Phospho-tau ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

according to Alzheimer's Disease International. Prior research has focused on tangible symptoms of the disease, like amyloid plaques, tau tangles, inflammation and cellular dysfunction ...